https://www.selleckchem.com/pr....oducts/hsp990-nvp-hs
Effective clinical intervention strategies for coronavirus disease 2019 (COVID-19) are urgently needed. Although several clinical trials have evaluated use of convalescent plasma containing virus-neutralizing antibodies, levels of neutralizing antibodies are usually not assessed and the effectiveness has not been proven. We show that hamsters treated prophylactically with a 12560 titer of human convalescent plasma or a 15260 titer of monoclonal antibody were protected against weight loss, had a significant reduction of virus r
Like
Comment
Share
